LSBio The Immunohistochemistry Antibody Company
  • Home
  • Products
    • All Antibodies
    • IHC-plus Antibodies
  • Services
    • Immunohistochemistry Studies
    • Tissue Cross-Reactivity Screening
  • Distributors
  • Resources
    • About our Tissue Bank
    • Customer Support
    • How to Buy
    • IHC-plus Protocol
    • LSBio Media
    • Publications
    • Antibody Reports
  • Company
    • About LifeSpan
    • Press Releases
    • Holiday Schedule
    • Contact Us
  • View Cart

General Cancer Screen 167 Tissue Microarray - LS-SCA167

This tissue microarray is available for use in LSBio Immunohistochemistry Studies only.

Catalog ID: LS-SCA167
Product Name: General Cancer Screen 167
Description: 6 common types of cancer with stage/grade and matched normal/non-neoplastic specimens
Format: FFPE
Category: Human Multi-Tumor and Normal
QA/QC: H&E reviewed
Storage: Short term RT; Long term 4ºC
Clinical History: No
Tissue Marker: No
Stage/Grade: Yes
Cases: 58
Cores: 66
Slides Per Set: 1

LS-SCA167 Tissue Microarray Map

Slide Number 1
LABEL
 1234567891011
APlaUnkOvaOvaOvaOvaOvaOvaOvaOvaOva
BBlaBlaBlaBlaBlaBlaBlaBlaBlaBlaBla
CBstBstBstBstBstBstBstBstBstBstBst
DKidKidKidKidKidKidKidKidKidKidKid
EUteUteUteUteUteUteUteUteUteUteUte
FLngLngLngLngLngLngLngLngLngLngLng
Diagnosis Type Legend
Benign non-neoplasticDiseasedInflammatoryMalignantMetastaticTumorUnknown
Element Tissue Legend
Bladder (Bla); Breast (Bst); Kidney (Kid); Lung (Lng); Ovary (Ova); Placenta (Pla); Unknown (Unk); Uterus (Ute);

LS-SCA167 Element Details

SlidePositionSpeciesGenderAgeTissueDiagnosisDiagnosis TypeTNM Tumor ClassificationTumor DifferentiationTumor Size
1A1HumanF29 yPlacenta (Pla)NormalBenign non-neoplastic   
1A2HumanU Unknown (Unk)NormalBenign non-neoplastic   
1A3HumanF40 yOvary (Ova)Adenocarcinoma, MucinousMalignantT3N2M1Poorly7x5x5 cm
1A4HumanF60 yOvary (Ova)AdenocarcinomaMalignantT3N1M1Poorly5x5x4 cm
1A5HumanF50 yOvary (Ova)AdenocarcinomaMalignantT3N0M0Moderately5x5x4.5 cm
1A6HumanF63 yOvary (Ova)Cystadenocarcinoma, SerousMalignantT3N1M0Moderately6x5x5 cm
1A7HumanF55 yOvary (Ova)Clear cell adenocarcinomaMalignantT3N0M0PoorlyDiameter 13.0 cm
1A8HumanF39 yOvary (Ova)Adjacent normalBenign non-neoplastic   
1A9HumanF39 yOvary (Ova)Cystadenoma, Serous and papillaryTumorT4N5M1Poorly15x14x9 cm
1A10HumanF51 yOvary (Ova)Adjacent normalBenign non-neoplastic   
1A11HumanF51 yOvary (Ova)ThecomaTumorModerately
1B1HumanM66 yBladder (Bla)Transitional cell carcinomaMalignantT2N0M0Moderately4x3x3 cm
1B2HumanM35 yBladder (Bla)Transitional cell carcinomaMalignantModerately
1B3HumanM61 yBladder (Bla)Transitional cell carcinomaMalignantT2N0M0Poorly4x3.5x1.5 cm
1B4HumanM77 yBladder (Bla)Transitional cell carcinoma, PapillaryMalignantT2N0M0Well3x3x1.5 cm
1B5HumanM75 yBladder (Bla)Transitional cell carcinomaMalignantT3N0M0Poorly6x5x2.5 cm
1B6HumanM69 yBladder (Bla)Transitional cell carcinoma, PapillaryMalignantT3N0M0Moderately8x8x1.5 cm
1B7HumanM69 yBladder (Bla)Transitional cell carcinoma, PapillaryMalignantT2N0M0Moderately3x3x2 cm
1B8HumanF58 yBladder (Bla)Adjacent normalBenign non-neoplastic   
1B9HumanF58 yBladder (Bla)Transitional cell carcinomaMalignantT2N0M0Moderately4x4x2.5 cm
1B10HumanM20 yBladder (Bla)Adjacent normalBenign non-neoplastic   
1B11HumanM20 yBladder (Bla)Transitional cell carcinomaMalignantT2N0M0Well3x3x1.5 cm
1C1HumanF48 yBreast (Bst)Ductal carcinoma, infiltratingMalignantT2N0M0ModeratelyDiameter 4.0 cm
1C2HumanF44 yBreast (Bst)Lobular carcinoma, infiltratingMalignantWell6x4x4 cm
1C3HumanF82 yBreast (Bst)Ductal carcinoma, infiltratingMalignantT3N4M1Moderately5x6 cm
1C4HumanF41 yBreast (Bst)Ductal carcinoma, infiltratingMalignantT2N1M0Moderately1x1x0.8 cm
1C5HumanF78 yBreast (Bst)Ductal carcinoma, infiltratingMalignantT2N1M0Moderately3x2 cm
1C6HumanF26 yBreast (Bst)FibroadenomaTumorT2N0M01.8x1.5x0.7 cm
1C7HumanF58 yBreast (Bst)Ductal carcinoma, infiltratingMalignantT3N3M0Moderately6x5x4 cm
1C8HumanF56 yBreast (Bst)Adjacent normalBenign non-neoplastic   
1C9HumanF56 yBreast (Bst)Ductal carcinoma, infiltratingMalignantT3N0M0Moderately5x2x3 cm
1C10HumanF36 yBreast (Bst)Adjacent normalBenign non-neoplastic   
1C11HumanF36 yBreast (Bst)Ductal carcinoma, infiltratingMalignantT2N0M0Well2x2 cm
1D1HumanM50 yKidney (Kid)Clear cell carcinomaMalignantT2N0M0Well3.5x3.5x3.2 cm
1D2HumanM70 yKidney (Kid)Clear cell carcinomaMalignantT3N0M0Poorly5.5x5 cm
1D3HumanM64 yKidney (Kid)Clear cell carcinomaMalignantT2N0M0Moderately4x3x3 cm
1D4HumanM48 yKidney (Kid)Clear cell carcinomaMalignantT2N0M0Moderately3x3x2.5 cm
1D5HumanM50 yKidney (Kid)Clear cell carcinomaMalignantT2N0M0Poorly-Moderately4x3x3 cm
1D6HumanF50 yKidney (Kid)Clear cell carcinomaMalignantT3N0M0Moderately6.5x5x5 cm
1D7HumanM70 yKidney (Kid)Clear cell carcinomaMalignantT3N0M0Moderately6x5x5 cm
1D8HumanM60 yKidney (Kid)Adjacent normalBenign non-neoplastic   
1D9HumanM60 yKidney (Kid)Transitional cell carcinomaMalignantT3N0M0Moderately6x4x2.5 cm
1D10HumanM33 yKidney (Kid)Adjacent normalBenign non-neoplastic   
1D11HumanM33 yKidney (Kid)Renal cell carcinomaMalignantT2N0M0Moderately2.5x2x2 cm
1E1HumanF70 yUterus (Ute)Endometrial papillary adenocarcinomaMalignantT2N0M0Moderately3x2x1 cm
1E2HumanF49 yUterus (Ute)Endometrial adenocarcinomaMalignantT3N0M0Moderately10x8x1.5 cm
1E3HumanF61 yUterus (Ute)AdenocarcinomaMalignantT1N2M0WellDiameter 0.3 cm
1E4HumanF25 yUterus (Ute)Squamous cell carcinomaMalignantT3N0M0Poorly5x2.5 cm
1E5HumanF36 yUterus (Ute)AdenomyomaTumorDiameter 7.5 cm
1E6HumanF42 yUterus (Ute)AdenomaTumorDiameter 4.0 cm
1E7HumanF66 yUterus (Ute)Endometrial adenocarcinomaMalignantT2N0M0Well3x0.4x0.2 cm
1E8HumanF52 yUterus (Ute)Adjacent normalBenign non-neoplastic   
1E9HumanF52 yUterus (Ute)LeiomyomaTumor5x5x4 cm
1E10HumanF50 yUterus (Ute)Adjacent normalBenign non-neoplastic   
1E11HumanF50 yUterus (Ute)LeiomyomaTumor3x2x2 cm
1F1HumanM58 yLung (Lng)Squamous cell carcinomaMalignantT3N2M0Moderately5x4x4 cm
1F2HumanM46 yLung (Lng)Squamous cell carcinomaMalignantT3N2M0Moderately6x5x5 cm
1F3HumanM63 yLung (Lng)Squamous cell carcinomaMalignantT2N3M0Moderately3x3x2 cm
1F4HumanM62 yLung (Lng)Squamous cell carcinomaMalignantT3N1M0Poorly-Moderately5x4x4 cm
1F5HumanF60 yLung (Lng)AdenocarcinomaMalignantT2N4M0Poorly4x3.5x3.2 cm
1F6HumanM60 yLung (Lng)Squamous cell carcinomaMalignantT2N4M0Moderately3.7x3x3 cm
1F7HumanF62 yLung (Lng)Squamous cell carcinomaMalignantT2N1M0Poorly3x2.5x2.2 cm
1F8HumanF50 yLung (Lng)Adjacent normalBenign non-neoplastic   
1F9HumanF50 yLung (Lng)AdenocarcinomaMalignantT2N5M1Poorly-Moderately3x3x2.5 cm
1F10HumanM63 yLung (Lng)Adjacent normalBenign non-neoplastic   
1F11HumanM63 yLung (Lng)Bronchioalveolar carcinomaMalignantT3N4M1Moderately7x5x5 cm
PLEASE NOTE

For RESEARCH USE ONLY. Not intended for human diagnostic or therapeutic purposes.

Not for resale without prior written consent from LifeSpan BioSciences, Inc.

Copyright © 2013 LifeSpan BioSciences, Inc. All Rights Reserved